14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
FAZ vs TZA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
FAZ Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)
FAZ Overall Winner
6-Pillar Tally: FAZ 0 – 0 TZA (6 Tie)
Matrix Metrics: FAZ 2 – 1 TZA
As of Nov 16, 2026, Direxion Daily Financial Bear 3x Shares (FAZ) is the stronger overall head-to-head candidate over Direxion Daily Small Cap Bear 3x Shares (TZA) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FAZ carries a Unified Composite Score of 60.5/100 (BUY) at $30.45 (N/M Forward P/E, N/A operating margin), whereas TZA carries 55.1/100 (HOLD) at $49.28 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FAZ vs TZA. Trailing 12-month operating profitability (FAZ N/A vs TZA N/A) and valuation multiples (FAZ N/M vs TZA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ FAZ vs TZA Key Questions & Quantitative Answers
As of Nov 16, 2026, Direxion Daily Financial Bear 3x Shares (FAZ) is the stronger overall head-to-head candidate over Direxion Daily Small Cap Bear 3x Shares (TZA) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FAZ carries a Unified Composite Score of 60.5/100 (BUY) at $30.45 (N/M Forward P/E, N/A operating margin), whereas TZA carries 55.1/100 (HOLD) at $49.28 (N/M Forward P/E, N/A operating margin). Technically, FAZ sits in a Neutral phase (RSI 42.2, UNCLASSIFIED options structure) and TZA sits in a Markup phase (RSI 56.2, UNCLASSIFIED options structure).
FAZ and TZA split Growth & Scale metrics: FAZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TZA at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, FAZ generates N/A in USD-normalized revenue versus N/A for TZA. In operating R&D and SG&A reinvestment, FAZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TZA.
FAZ and TZA trade at balanced relative valuation multiples. FAZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TZA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FAZ (N/A ROE) versus TZA (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, FAZ carries 37.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.49β · 61% Vol realized risk). By comparison, TZA carries 61.3% implied volatility (14th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.19β · 75% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.